I agree because Joe and Generex have on numerous occasions said that Veneto, Excellagen etc are ready to generate significant revenue. Repeatedly. And revenue actually somehow lowering itself for the fiscal year isn’t something that anyone should be criticized for asking about. It should have been explained within in K or upon release along with go forward plans. Conference calls at 9:30 am are hard for most to participate in.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links